Philip has been the CEO and Managing Director of PainChek Ltd based in Sydney, Australia, since October 2016. PainChek is the world's first pain assessment app that has regulatory clearance in Australia and Europe. Using AI and facial recognition technology, PainChek automatically identifies, quantifies and monitors pain to help give a voice to those who cannot verbalise their pain. He is a highly accomplished global business leader and people manager with an international career spanning more than 25 years with leading blue-chip healthcare corporations including Cochlear, Roche Diagnostics, Bio-Rad Laboratories, and novel technology start-up companies. 

Philip has held senior global business leadership positions in Europe, US and Australia. He has developed extensive global business and customer relationships in the areas of interventional cardiovascular disease management, diabetes care and blood glucose management, ENT/audiology and cochlear implantation, intensive care management, pathology in vitro blood diagnostics and life science research technologies. His roles in Australia have included VP Global Marketing at Cochlear and General Management with Roche Diagnostics and Bio-Rad Laboratories, and CEO of Applied Physiology, an Australian start-up software company in the intensive care monitoring sector.

Philip has an electronic engineering background, has obtained diplomas in industrial management and marketing and has an MBA from Kingston University in UK. He also is a Graduate of the Australian Institute of Company Directors (GAICD).